Delivery Order SPE2DR25D2207-SPE2DR26F0L41
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,528.32 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This non-competitive delivery order carries a firm fixed price and is scheduled for completion by September 8, 2025. The award was made to AmerisourceBergen's Corporate Office division, headquartered in Conshohocken, Pennsylvania, where the products will be supplied from. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,249.10 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order was executed on October 22, 2025, with an ultimate completion date of October 23, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,716.08 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitive, non-set-aside contract was executed on November 17, 2025, with an ultimate completion date of November 18, 2025, utilizing firm fixed pricing. The award is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the vendor maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $15,088.92 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens. The award, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,499.40 on November 14, 2025, for Humulin R 500 Unit/ML KwikPen 3ML insulin pens. This competitive award, which carries a firm fixed price structure and an ultimate completion date of November 17, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Humulin R 500 Unit/ML KwikPen 3ML insulin pens, valued at $12,000.90. This is a firm fixed price delivery order with no set-aside designation, representing a competitive award. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,377.05 to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen 3mL insulin pens on May 5, 2025, with completion scheduled for May 6, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humulin R 500 Unit/mL KwikPen insulin pens (3 mL) with a ceiling value of $17,358.71 under a firm fixed-price arrangement. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a direct purchase of pharmaceutical supplies with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $14,801.88 to AmerisourceBergen Drug Corp for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. Issued on June 2, 2025, with an ultimate completion date of June 3, 2025, this firm fixed-price delivery order represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a $2,249.10 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Humulin R 500 Unit/mL KwikPen 3mL insulin pens. This competitively awarded, non-set-aside contract utilized firm fixed pricing and is scheduled for completion by December 5, 2025. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DR25D2207Indefinite Delivery Contract
- SPE2DR25D2207-SPE2DR26F0L41Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,476.79 to AmerisourceBergen Drug Corp for Humulin R 500 unit/mL KwikPen 3mL insulin pens. This firm fixed-price delivery order, issued on December 12, 2025, is expected to be completed by December 15, 2025, and will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made without a set-aside designation, indicating competitive procurement. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle running through December 2026 that serves as a global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of pharmaceutical and medical supply deliveries to the Defense Logistics Agency and Defense Health Agency. The company's SPE2DX IDC enables it to supply a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare systems worldwide. The Humulin R insulin delivery under this order supports diabetes management needs within the Defense Health Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/11/25 |